On October 4, 2021 ENTEROME SA, a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases, reported that Pierre Belichard, CEO, will attend and take part in 1-on-1 meetings with institutional investors at the following conferences (Press release, Enterome, OCT 4, 2021, View Source;utm_medium=rss&utm_campaign=enterome-to-attend-upcoming-conferences [SID1234590744]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
• BMO fall Life Sciences Private Company Showcase: October 14
• Jefferies Annual IBD Next Generation Therapeutics Summit: October 19
• Jefferies Global Healthcare Conference: November 16 -18